| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43cbfb55f3b59c89de502eb3efaf8308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3ac76a69ebd2ab272ce5d50d9ada6aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d06164cdd6a306165b95ef92104e39aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1191a6060d84289df281668d382e9123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10ee11f5cb1e332753e828662bd2c432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa8ff28a2f36e44eb00bf89b2a9c346d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e071d18fea054bf8d1420d483e78ed1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3fef576488b8475284e9864c6340eb1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-101 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2004-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e996f951c3c23ae2616c6086c6f749ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fad9838a29716eb19d6e76cb46b68892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b1c9ba20f1e9f372645ad3b6d4f053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44dc11ea72bd92b0b162af89bbd79a02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae1dd155a62197df2b477af85e2ab594
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_064e78d073d0c26b0773bf43502d0e80 |
| publicationDate |
2004-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004069200-A2 |
| titleOfInvention |
Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
| abstract |
Isolated peptide fragments of the conserved regulatory domain of NFAT protein capable of inhibiting protein-protein interaction between calcineurin and NFAT, or a biologically active analog thereof are described. Isolated polynucleotides and gene therapy vectors encoding such peptide fragments are also described. In addition, methods for treating immune-related diseases or conditions and methods for high throughput screening of candidate agents are described. Pharmaceutical compositions are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9926306-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013518816-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10000511-B2 |
| priorityDate |
1998-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |